SCHEMBL4497673

SCHEMBL4497673

CCOC(=O)c1c(O)c2c(C)scc2n(C)c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.57
KDM4E B2RXH2 5/20 0.57
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
PABPC1 P11940 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
PKM P14618 1/20 0.44
NPC1 O15118 1/20 0.44
ALOX15 P16050 1/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FEN1 P39748 2/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4517627 0.79 ALDH1A1 (0.51) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL2497674 0.76 ALDH1A1 (0.61) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL7598991 0.76 ALDH1A1 (0.68) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL10044901 0.75 ALDH1A1 (0.67) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL1685962 0.74 ALDH1A1 (0.65) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL7597398 0.74 ALDH1A1 (0.65) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL4510892 0.74 KMT2A (0.63) ALDH1A1KDM4EMEN1POLBKMT2A
SCHEMBL2498218 0.74 ALDH1A1 (0.51) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL2574687 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1POLBPABPC1
SCHEMBL6996658 0.73 ALDH1A1 (0.64) ALDH1A1KDM4EMEN1POLBPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 ALDH1A1 3955/4885KDM4E 1493/4885MEN1 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.